arrow
H

Henry F. Chambers

San Francisco General Hospital
H指数:88
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stk1 is required for BlaR1-mediated broad-spectrum β-lactam resistance in epidemic-causing strains of Staphylococcus aureus

Stk1对于金黄色葡萄球菌流行致病菌株中BlaR1介导的广谱β-内酰胺类抗生素耐药性是必需的

2026-09-160
OAAI
Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial
2025-11-120
OA
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies

诊断意向和诊断准确性研究中不同的研究重点

2025-03-270
PRE
Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing Enterobacter Species From an International Cohort

来自国际队列的产碳青霉烯酶肠杆菌的分子流行病学和临床特征

2024-12-120
PRE
Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes

住院的澳大利亚儿童的革兰氏阴性血流感染的特征及其临床结果

2024-06-250
OAAI
Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

使用六项抗菌药物注册试验探索医院获得性细菌性肺炎和呼吸机相关细菌性肺炎的潜在DOOR终点

2024-03-250
OA
In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in US hospitals

在美国医院收集的舒巴坦-硬洛巴坦对多粘菌素耐药和/或头孢地洛尔非敏感,耐碳青霉烯的鲍曼不动杆菌的体外活性

2024-03-0611
OA